These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 28512247)
21. Overexpression of Large-Conductance Calcium-Activated Potassium Channels in Human Glioblastoma Stem-Like Cells and Their Role in Cell Migration. Rosa P; Sforna L; Carlomagno S; Mangino G; Miscusi M; Pessia M; Franciolini F; Calogero A; Catacuzzeno L J Cell Physiol; 2017 Sep; 232(9):2478-2488. PubMed ID: 27606467 [TBL] [Abstract][Full Text] [Related]
22. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme. Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242 [TBL] [Abstract][Full Text] [Related]
23. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells. Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313 [TBL] [Abstract][Full Text] [Related]
24. The effects of type I interferon on glioblastoma cancer stem cells. Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846 [TBL] [Abstract][Full Text] [Related]
25. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo. Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379 [TBL] [Abstract][Full Text] [Related]
27. Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide. Schmid RS; Simon JM; Vitucci M; McNeill RS; Bash RE; Werneke AM; Huey L; White KK; Ewend MG; Wu J; Miller CR Neuro Oncol; 2016 Jul; 18(7):962-73. PubMed ID: 26826202 [TBL] [Abstract][Full Text] [Related]
28. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt. El-Sehemy A; Selvadurai H; Ortin-Martinez A; Pokrajac N; Mamatjan Y; Tachibana N; Rowland K; Lee L; Park N; Aldape K; Dirks P; Wallace VA J Clin Invest; 2020 Jun; 130(6):3069-3086. PubMed ID: 32182224 [TBL] [Abstract][Full Text] [Related]
29. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide. Pojo M; Gonçalves CS; Xavier-Magalhães A; Oliveira AI; Gonçalves T; Correia S; Rodrigues AJ; Costa S; Pinto L; Pinto AA; Lopes JM; Reis RM; Rocha M; Sousa N; Costa BM Oncotarget; 2015 Apr; 6(10):7657-74. PubMed ID: 25762636 [TBL] [Abstract][Full Text] [Related]
30. The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling. Peng C; Chen Z; Wang S; Wang HW; Qiu W; Zhao L; Xu R; Luo H; Chen Y; Chen D; You Y; Liu N; Wang H Cancer Res; 2016 Apr; 76(8):2340-53. PubMed ID: 26960975 [TBL] [Abstract][Full Text] [Related]
31. A cell-autonomous positive-signaling circuit associated with the PDGF-NO-ID4-regulatory axis in glioblastoma cells. Eun K; Jeon HM; Kim SO; Choi SH; Lee SY; Jin X; Kim SC; Kim H Biochem Biophys Res Commun; 2017 Apr; 486(2):564-570. PubMed ID: 28327358 [TBL] [Abstract][Full Text] [Related]
32. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243 [TBL] [Abstract][Full Text] [Related]
33. [Impact of calcium channel antagonists for estrogen action on the endometrial carcinoma HEC-1A cells]. Bao XX; Wang JL; Wei LH Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):212-7. PubMed ID: 22781074 [TBL] [Abstract][Full Text] [Related]
34. The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness. Voss DM; Sloan A; Spina R; Ames HM; Bar EE Cancer Res; 2020 Nov; 80(21):4681-4692. PubMed ID: 32928918 [TBL] [Abstract][Full Text] [Related]
35. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969 [TBL] [Abstract][Full Text] [Related]
36. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells. Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389 [TBL] [Abstract][Full Text] [Related]
37. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells. Ohkubo T; Yamazaki J Int J Oncol; 2012 Jul; 41(1):267-75. PubMed ID: 22469755 [TBL] [Abstract][Full Text] [Related]
38. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction. Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841 [TBL] [Abstract][Full Text] [Related]
39. Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells. Wu N; Liu J; Zhao X; Yan Z; Jiang B; Wang L; Cao S; Shi D; Lin X Tumour Biol; 2015 Dec; 36(12):9667-76. PubMed ID: 26150336 [TBL] [Abstract][Full Text] [Related]
40. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]